Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Analyst consensus.
ACCE opinionAtlanta Braves Holdings Inc. Series C Common Stock (BATRK)
Fair value
Not available
ACCE price target
$54.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Price used: $49.64 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
38
out of 100
Analysts
60% buy
5 covering
1-year return
+25.4%
Dividend yield
0.00%
Atlanta Braves Holdings Inc. Series C Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Atlanta Braves Holdings owns the Atlanta Braves Major League Baseball club, the Truist Park stadium and mixed-use development known as The Battery, and a set of regional sports and media rights that feed its Braves broadcasting income. The case for a closer look rests on owning a scarce, locally anchored sports asset whose value sits in long-dated media contracts and real estate rather than in quarterly earnings. The near-term problem is visible in the numbers: revenue is shrinking 2.3%, the operating margin is negative at -6.1%, and return on equity is -12.0%, so the investment case depends on whether the franchise's real estate and media economics can carry the company until operations improve. A forward P/E of 2500 and a trailing P/E of zero mean earnings are too small to anchor valuation, which pushes any decision onto sum-of-the-parts work on the stadium, the development and the rights. Our composite score is 39/100 and the stock is in no major index, which argues for a deliberate, narrow review rather than a quick judgment.